Filing Details

Accession Number:
0001179110-10-011225
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-07-01 13:00:00
Reporting Period:
2010-06-30
Filing Date:
2010-07-01
Accepted Time:
2010-07-01 19:42:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1061027 Sunesis Pharmaceuticals Inc SNSS Pharmaceutical Preparations (2834) 943295878
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1289884 B Steven Ketchum C/O Sunesis Pharmaceuticals, Inc.
395 Oyster Point Blvd., Suite 400
South San Francisco CA 94080
Sr. Vice President, R & D No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-06-30 238,243 $0.28 240,595 No 4 P Direct
Common Stock Acquisiton 2010-06-30 99,940 $0.00 340,535 No 4 C Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 C Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2010-06-30 9,994 $0.00 99,940 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
Footnotes
  1. The Series A Preferred Stock automatically converted into common stock in accordance with the terms of the applicabale Certificate of Designation of the Issuer on a 1-for-10 basis and had no expiration date.